While not yet FDA-approved as a standalone agent, cagrilintide peptide therapy is being investigated for: Obesity treatment Metabolic syndrome management Adjunctive therapy for GLP-1 agonist non-responders Research in combination with emerging agents like retatrutide Note: As of 2025, cagrilintide is still considered a research compound in many jurisdictions
In South Korea, dutasteride received regulatory approval specifically for androgenetic alopecia, and prescribing for hair loss under physician supervision is standard practice in many countries
By disrupting a microsomal glutathione S-transferase (mGST) like gene these authors showed that the mutant flies had a significantly reduced life-span compared to controls
NAC, or N-acetylcysteine, is a supplement form of the amino acid cysteine
The BCS1L encoded protein is a member of the AAA family of ATPases
Taking a 30-day break allows receptors to reset and regain sensitivity, ensuring that the next cycle remains effective